Table 2.
Two-way ANOVA for different treatments, processing days, and their interaction on enzyme activity.
| Effect Tested | SOD Activity | CAT Activity | GSH-Px Activity |
|---|---|---|---|
| Treatments (T) | |||
| Control | 3.70 ± 2.34d | 38.67 ± 11.66d | 0.96 ± 0.46e |
| 0.05% RBP extract | 4.47 ± 2.08c | 43.02 ± 10.66c | 1.18 ± 0.33c |
| 0.03% Quercetin | 5.62 ± 1.55a | 43.96 ± 10.08b,c | 1.10 ± 0.36d |
| 0.03% Rutin | 4.56 ± 2.09c | 46.21 ± 8.44a,b | 1.27 ± 0.31b |
| 0.03% Kaempferol | 5.00 ± 2.08b | 47.63 ± 6.96a | 1.37 ± 0.25a |
| Significance | *** | *** | *** |
| Processing days (D) | |||
| 0 | 7.70 ± 0.10A | 57.92 ± 1.95A | 1.65 ± 0.04A |
| 3 | 5.63 ± 0.92B | 49.15 ± 3.81B | 1.37 ± 0.15B |
| 6 | 4.60 ± 0.78C | 43.52 ± 3.01C | 1.18 ± 0.20C |
| 9 | 3.41 ± 0.86D | 35.80 ± 5.34D | 0.97 ± 0.22D |
| 12 | 2.00 ± 0.81E | 33.09 ± 5.47E | 0.70 ± 0.20E |
| Significance | *** | *** | *** |
| Interaction T × D | *** | *** | *** |
Note: *** = p < 0.001; different small letters (a–e) in the treatments and capital letters (A–E) in the processing days means significant differences.